Yili Chuanning Biotechnology Co.,Ltd. (301301.SZ)
- Previous Close
13.20 - Open
14.50 - Bid 12.91 x --
- Ask 12.92 x --
- Day's Range
12.86 - 13.28 - 52 Week Range
10.41 - 16.58 - Volume
45,929,905 - Avg. Volume
32,129,228 - Market Cap (intraday)
28.775B - Beta (5Y Monthly) 0.19
- PE Ratio (TTM)
21.53 - EPS (TTM)
0.60 - Earnings Date --
- Forward Dividend & Yield 0.22 (1.70%)
- Ex-Dividend Date May 22, 2024
- 1y Target Est
15.00
Yili Chuanning Biotechnology Co.,Ltd. engages in the research and development, and industrialization of biological fermentation technology in China. It offers antibiotic intermediates, such as erythromycin thiocyanate, penicillin G potassium salt, 6-aminopenicillanic acid, 7-aminocephalosporanic acid, 7-aminodesacetoxycephalosporanic acid, desacetyl-7-aminocephalosporanic acid, and ursodeoxycholic acid. Yili Chuanning Biotechnology Co.,Ltd. was incorporated in 2010 and is based in Yining, China.
www.klcnsw.comRecent News: 301301.SZ
View MorePerformance Overview: 301301.SZ
Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 301301.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 301301.SZ
View MoreValuation Measures
Market Cap
29.40B
Enterprise Value
29.66B
Trailing P/E
22.00
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.31
Price/Book (mrq)
3.59
Enterprise Value/Revenue
5.36
Enterprise Value/EBITDA
18.06
Financial Highlights
Profitability and Income Statement
Profit Margin
24.15%
Return on Assets (ttm)
9.70%
Return on Equity (ttm)
17.19%
Revenue (ttm)
5.53B
Net Income Avi to Common (ttm)
1.34B
Diluted EPS (ttm)
0.60
Balance Sheet and Cash Flow
Total Cash (mrq)
1.14B
Total Debt/Equity (mrq)
17.14%
Levered Free Cash Flow (ttm)
1.56B